Ligand validation:1N9O

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 1N9O designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1N9O_FMN_A_1001	32%	7%	0.227	0.901	2.67	2.08	17	13	1	0	100%	1
8QI8_FMN_A_500	100%	43%	0.045	0.985	1.07	1.15	2	4	0	0	100%	1
8QI9_FMN_A_500	94%	32%	0.081	0.979	1.36	1.36	4	7	5	0	100%	0.96
8QIF_FMN_A_500	86%	34%	0.086	0.955	1.04	1.56	2	6	2	0	100%	0.953
8QIH_FMN_A_500	86%	28%	0.089	0.957	1.07	1.82	2	8	2	0	100%	0.951
8QIG_FMN_A_500	86%	31%	0.098	0.965	1.09	1.62	2	8	1	0	100%	0.951
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	1
9DKQ_FMN_A_1002	100%	42%	0.026	0.997	1.03	1.22	2	7	0	0	100%	1
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	3	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHG_FMN_A_401	100%	64%	0.027	0.994	0.65	0.73	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.